PharmaTher Holdings (XCNQ:PHRM) YoY EBITDA Growth : 44.44% (As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PharmaTher Holdings's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was 44.44%.

PharmaTher Holdings's EBITDA per Share for the three months ended in Feb. 2024 was C$-0.01.

PharmaTher Holdings YoY EBITDA Growth Historical Data

The historical data trend for PharmaTher Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings YoY EBITDA Growth Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

YoY EBITDA Growth

-34.21

9.80

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
YoY EBITDA Growth	Get a 7-Day Free Trial										30.77	23.53	-7.14	-11.11	44.44

PharmaTher Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PharmaTher Holdings's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

	YoY EBITDA Growth (A: May. 2023 )
=	(EBITDA per Share (A: May. 2023 )	-	EBITDA per Share (A: May. 2022 ))	/	\| EBITDA per Share (A: May. 2022 ) \|
=	(-0.046	-	-0.051)	/	\| -0.051 \|
=	9.80 %

PharmaTher Holdings's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2024 )
=	(EBITDA per Share (Q: Feb. 2024 )	-	EBITDA per Share (Q: Feb. 2023 ))	/	\| EBITDA per Share (Q: Feb. 2023 )) \|
=	(-0.005	-	-0.009)	/	\| -0.009 \|
=	44.44 %

PharmaTher Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

PHRRF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

Executives

Fabio Chianelli

Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines